BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33308842)

  • 1. Dietary protein and protein substitute requirements in adults with phenylketonuria: A review of the clinical guidelines.
    Firman S; Witard OC; O'Keeffe M; Ramachandran R
    Clin Nutr; 2021 Mar; 40(3):702-709. PubMed ID: 33308842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updated, web-based nutrition management guideline for PKU: An evidence and consensus based approach.
    Singh RH; Cunningham AC; Mofidi S; Douglas TD; Frazier DM; Hook DG; Jeffers L; McCune H; Moseley KD; Ogata B; Pendyal S; Skrabal J; Splett PL; Stembridge A; Wessel A; Rohr F
    Mol Genet Metab; 2016 Jun; 118(2):72-83. PubMed ID: 27211276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein Substitutes in PKU; Their Historical Evolution.
    Daly A; Evans S; Pinto A; Ashmore C; MacDonald A
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33540516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Over Restriction of Dietary Protein Allowance: The Importance of Ongoing Reassessment of Natural Protein Tolerance in Phenylketonuria.
    Pinto A; Almeida MF; MacDonald A; Ramos PC; Rocha S; Guimas A; Ribeiro R; Martins E; Bandeira A; Jackson R; van Spronsen F; Payne A; Rocha JC
    Nutrients; 2019 Apr; 11(5):. PubMed ID: 31052331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein status of people with phenylketonuria: a scoping review protocol.
    Firman S; Ramachandran R; Whelan K; Witard OC; O'Keeffe M
    BMJ Open; 2021 Sep; 11(9):e049883. PubMed ID: 34521668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of three preterm infants with phenylketonuria.
    Weiss K; Lotz-Havla A; Dokoupil K; Maier EM
    Nutrition; 2020 Mar; 71():110619. PubMed ID: 31864970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy of 'ready-to-drink' protein substitute in phenylketonuria.
    Gokmen-Ozel H; MacDonald A; Daly A; Hall K; Ryder L; Chakrapani A
    J Hum Nutr Diet; 2009 Oct; 22(5):422-7. PubMed ID: 19743980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled trial of a protein substitute with prolonged release on the protein status of children with phenylketonuria.
    Giovannini M; Riva E; Salvatici E; Cefalo G; Radaelli G
    J Am Coll Nutr; 2014; 33(2):103-10. PubMed ID: 24724767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein metabolism in adult patients with phenylketonuria.
    van Rijn M; Hoeksma M; Sauer P; Szczerbak B; Gross M; Reijngoud DJ; van Spronsen F
    Nutrition; 2007 Jun; 23(6):445-53. PubMed ID: 17507200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary management practices in phenylketonuria across European centres.
    Ahring K; Bélanger-Quintana A; Dokoupil K; Gokmen Ozel H; Lammardo AM; MacDonald A; Motzfeldt K; Nowacka M; Robert M; van Rijn M
    Clin Nutr; 2009 Jun; 28(3):231-6. PubMed ID: 19362397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilisation of amino acid mixtures in adolescents with phenylketonuria.
    Mönch E; Herrmann ME; Brösicke H; Schöffer A; Keller M
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S115-20. PubMed ID: 8828625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between dietary intake, growth and body composition in Phenylketonuria.
    Evans M; Truby H; Boneh A
    Mol Genet Metab; 2017 Sep; 122(1-2):36-42. PubMed ID: 28739202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practices in prescribing protein substitutes for PKU in Europe: No uniformity of approach.
    Aguiar A; Ahring K; Almeida MF; Assoun M; Belanger Quintana A; Bigot S; Bihet G; Blom Malmberg K; Burlina A; Bushueva T; Caris A; Chan H; Clark A; Clark S; Cochrane B; Corthouts K; Dalmau J; Dassy M; De Meyer A; Didycz B; Diels M; Dokupil K; Dubois S; Eftring K; Ekengren J; Ellerton C; Evans S; Faria A; Fischer A; Ford S; Freisinger P; Giżewska M; Gokmen-Ozel H; Gribben J; Gunden F; Heddrich-Ellerbrok M; Heiber S; Heidenborg C; Jankowski C; Janssen-Regelink R; Jones I; Jonkers C; Joerg-Streller M; Kaalund-Hansen K; Kiss E; Lammardo AM; Lang K; Lier D; Lilje R; Lowry S; Luyten K; MacDonald A; Meyer U; Moor D; Pal A; Robert M; Robertson L; Rocha JC; Rohde C; Ross K; Saruhan S; Sjöqvist E; Skeath R; Stoelen L; Ter Horst NM; Terry A; Timmer C; Tuncer N; Vande Kerckhove K; van der Ploeg L; van Rijn M; van Spronsen FJ; van Teeffelen-Heithoff A; van Wegberg A; van Wyk K; Vasconcelos C; Vitoria I; Wildgoose J; Webster D; White FJ; Zweers H
    Mol Genet Metab; 2015 May; 115(1):17-22. PubMed ID: 25862610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new, low-volume protein substitute for teenagers and adults with phenylketonuria.
    MacDonald A; Lilburn M; Cochrane B; Davies P; Daly A; Asplin D; Hall SK; Cousins A; Chakrapani A; Robinson P; Lee P
    J Inherit Metab Dis; 2004; 27(2):127-35. PubMed ID: 15159643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved Eating Behaviour and Nutrient Intake in Noncompliant Patients with Phenylketonuria after Reintroducing a Protein Substitute: Observations from a Multicentre Study.
    Green B; Rahman Y; Firman S; Adam S; Jenkinson F; Nicol C; Adams S; Dawson C; Robertson L; Dunlop C; Cozens A; Hubbard G; Stratton R
    Nutrients; 2019 Aug; 11(9):. PubMed ID: 31480383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weaning infants with phenylketonuria: a review.
    MacDonald A; Evans S; Cochrane B; Wildgoose J
    J Hum Nutr Diet; 2012 Apr; 25(2):103-10. PubMed ID: 21819461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-year retrospective analysis of patients with phenylketonuria (PKU) and hyperphenylalaninemia treated at two specialized clinics.
    Levy H; Lamppu D; Anastosoaie V; Baker JL; DiBona K; Hawthorne S; Lindenberger J; Kinch D; Seymour A; McIlduff M; Watling S; Vockley J
    Mol Genet Metab; 2020 Mar; 129(3):177-185. PubMed ID: 31883647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenylketonuria Scientific Review Conference: state of the science and future research needs.
    Camp KM; Parisi MA; Acosta PB; Berry GT; Bilder DA; Blau N; Bodamer OA; Brosco JP; Brown CS; Burlina AB; Burton BK; Chang CS; Coates PM; Cunningham AC; Dobrowolski SF; Ferguson JH; Franklin TD; Frazier DM; Grange DK; Greene CL; Groft SC; Harding CO; Howell RR; Huntington KL; Hyatt-Knorr HD; Jevaji IP; Levy HL; Lichter-Konecki U; Lindegren ML; Lloyd-Puryear MA; Matalon K; MacDonald A; McPheeters ML; Mitchell JJ; Mofidi S; Moseley KD; Mueller CM; Mulberg AE; Nerurkar LS; Ogata BN; Pariser AR; Prasad S; Pridjian G; Rasmussen SA; Reddy UM; Rohr FJ; Singh RH; Sirrs SM; Stremer SE; Tagle DA; Thompson SM; Urv TK; Utz JR; van Spronsen F; Vockley J; Waisbren SE; Weglicki LS; White DA; Whitley CB; Wilfond BS; Yannicelli S; Young JM
    Mol Genet Metab; 2014 Jun; 112(2):87-122. PubMed ID: 24667081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are tablets a practical source of protein substitute in phenylketonuria?
    MacDonald A; Ferguson C; Rylance G; Morris AA; Asplin D; Hall SK; Booth IW
    Arch Dis Child; 2003 Apr; 88(4):327-9. PubMed ID: 12651759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Inadequate Amino Acid Mixture Intake on Nutrient Supply of Adult Patients with Phenylketonuria.
    Hochuli M; Bollhalder S; Thierer C; Refardt J; Gerber P; Baumgartner MR
    Ann Nutr Metab; 2017; 71(3-4):129-135. PubMed ID: 28848183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.